dipyridamole has been researched along with alpha-aminopyridine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Dorigo, P; Maragno, I | 1 |
Alkadhi, KA; Brown, TR; Sabouni, MH | 1 |
Cronstein, BN; He, W; Mazumder, A; Wilder, T | 1 |
Deng, J; He, X; He, YM; Huang, Y; Huang, YY; Liu, H; Luo, HB; Wang, Q; Xie, X; Yuan, Y; Zhu, J | 1 |
4 other study(ies) available for dipyridamole and alpha-aminopyridine
Article | Year |
---|---|
Interaction of amrinone with endogenous adenosine in guinea-pig atria.
Topics: Adenosine; Adenosine Deaminase; Aminopyridines; Amrinone; Animals; Cardiac Glycosides; Cardiotonic Agents; Dipyridamole; Guinea Pigs; Heart; Heart Atria; In Vitro Techniques; Male; Myocardial Contraction; Reserpine; Theophylline | 1986 |
Inhibitory effect of adenosine on transmission in sympathetic ganglia.
Topics: 2-Chloroadenosine; 4-Aminopyridine; Action Potentials; Adenosine; Aminopyridines; Animals; Dipyridamole; Electric Stimulation; Female; Ganglia, Sympathetic; In Vitro Techniques; Neuromuscular Depolarizing Agents; Rats; Rats, Inbred Strains; Synaptic Transmission; Theophylline | 1984 |
Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma.
Topics: Acetamides; Adenosine; Aminopyridines; Animals; Bone and Bones; Cell Differentiation; Cells, Cultured; Dipyridamole; Female; Humans; Mice; Mice, Knockout; Multiple Myeloma; Osteocalcin; Osteoclasts; Purinergic P1 Receptor Agonists; Purines; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Reverse Transcriptase Polymerase Chain Reaction; Xanthines | 2013 |
Discovery of novel PDE4 inhibitors targeting the M-pocket from natural mangostanin with improved safety for the treatment of Inflammatory Bowel Diseases.
Topics: Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dextran Sulfate; Dipyridamole; Dogs; Inflammatory Bowel Diseases; Mice; Phosphodiesterase 4 Inhibitors | 2022 |